© 2012 – CRC Press
150 pages | 4 Color Illus. | 22 B/W Illus.
Evidenced-based texts are taking on a greater role in the education of healthcare providers. With an emphasis on this modality, this volume explores several topics related to the treatment of patients with the autoimmune form of arthritis known as rheumatoid arthritis. Topics include disease outcomes, leukocyte immunoglobulin-like receptors, cardiovascular risk associated with arthritis, cytokines, and alleles in rheumatoid arthritis. The book also examines various drugs used in treatment for pain relief and reduced inflammation.
Rheumatoid Arthritis, V. Ruffing
Disease Outcomes in Rheumatoid Arthritis, Roisin Adams
Cytokines in Rheumatoid Arthritis, Pia Isomäki
Leukocyte Immunoglobulin-like Receptors in Rheumatoid Arthritis, Nicodemus Tedla and Ahmer Hameed
Alleles and Rheumatoid Arthritis, María Verónica Aguirre-Arias, Carlos Vallejo Flores and Colin R. Martin
Cardiovascular Risk in Rheumatoid Arthritis, Elena Bartoloni, Alessia Alunno and Roberto Gerli
Drugs in Arthritis—An Overview, Stefano Alivernini, Elisa Gremese and Gianfranco Ferraccioli
Drugs in Focus in Arthritis—Leflunomide, Stefano Alivernini, Elisa Gremese and Gianfranco Ferraccioli